Table 3.
Patients data for SSTR2A results and PET/CT data
| Patient no./lesion, slide | IRS SSTR2A | Her2/neu SSTR2A | BB1 SSTR2A | SUVmax | SUVmean |
|---|---|---|---|---|---|
| 1/1 | 6 | 3+ | 0.4291 | 5.7 | 3.4 |
| 2/1 | 3 | 1+ | 9.2348 | 8.2 | 2.0 |
| 3/1 | 3 | 1+ | N/D | N/D | N/D |
| 3/2 | 4 | 1+ | 0.0906 | 4.3 | 2.1 |
| 4/1 | 12 | 3+ | 1.0434 | 13.6 | 8.1 |
| 5/1 | 9 | 3+ | N/D | 6.8 | 3.9 |
| 6/1 | 12 | 3+ | N/D | 33.7 | 21.0 |
| 7/1 | 4.5 | 3+ | 8.9353 | 8.3 | 4.9 |
| 8/1 | 12 | 3+ | 90.511 | 25.9 | 15.8 |
| 9/1 | 4 | 1+ | 0.8317 | 5.7 | 2.9 |
| 10/1 | 6 | 3+ | 4.5260 | 10.6 | 6.9 |
| 11/1 | 12 | 3+ | 0.9260 | 5.6 | 4.6 |
| 12/1 | 4 | 1+ | N/D | N/D | N/D |
| 12/2 | 12 | 3+ | N/D | 4.2 | 2.7 |
| 12/3 | 12 | 3+ | N/D | N/D | N/D |
| 12/4 | 12 | 3+ | N/D | 4.3 | 2.8 |
| 13/1 | 6 | 3+ | 1.0818 | 6.4 | 4.0 |
| 14/1 | 6 | 3+ | 4.9974 | 6.2 | 4.9 |
| 15/1 | 6 | 3+ | 10.024 | 17.4 | 10.0 |
| 16/1 | 4.5 | 3+ | 0.1238 | 14.8 | 9.5 |
| 16/2 | 6 | 3+ | 119.52 | 6.5 | 3.6 |
| 17/1 | 12 | 3+ | N/D | 10.5 | 6.5 |
| 18/1 | 12 | 3+ | 0.8516 | 12.6 | N/D |
| 19/1 | 12 | 3+ | 15.176 | 9.4 | 5.5 |
| 20/1 | 9 | 3+ | 4.5053 | 13.5 | 9.6 |
| 20/2 | 12 | 3+ | 14.520 | 9.6 | 5.9 |
| 21/1 | 5 | 3+ | 7.2947 | 14.6 | 9.0 |
| 22/1 | 12 | 3+ | 1.9985 | 12.4 | 9.1 |
| 23/1 | 12 | 3+ | 1.8545 | 8.4 | 4.8 |
| 24/1 | 3 | 1+ | 0.2441 | 4.9 | 2.8 |
| 25/1 | 8 | 2+ | 2.7681 | 6.7 | 2.0 |
Abbreviations: N/D - no data available; IRS - Immunoreactive score; Her2/neu - Her2/neu-score; BB1 - digital immunohistochemical score “Bad Berka 1”; SUVmax,-mean standardized uptake value maximum, -mean.